CYP1B1 and renal cell adenocarcinoma: To determine whether the CYP1B1 protein expression levels are related with the clinicopathologic features and risk of RCC progression, we analyzed 59 patient samples who underwent nephrectomy for RCC, 24 of whom also had adjacent normal kidney samples available for analysis by immunohistochemistry.